RTTNews BiotechCodex · 实盘不做把握 5/10
北京时间·🕒 发布 17:26:12时区推断·⟳ 抓取 17:30:48·⚡ 决策 07-13 17:34:23 +3m35s·106.4 天前
Alamar与美国研究型大学合作开展阿尔茨海默血液生物标志物研究项目
该事件是研究合作和数据集建设,未披露商业合同金额、采购规模或短期收入确认路径。
📄 原文RTTNews Biotech↗ 原文
Alamar Biosciences Partners With Leading Research Universities On National Biomarker Initiative Business Latest Headlin…
不做 Alamar Biosciences(ALMR.US)
科研合作未披露合同金额、采购义务或商业化收入路径,短线无法形成可量化正期望交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-13 · 扩散 low · price-in 风险 medium ↗
关键理由
- 该事件是研究合作和数据集建设,未披露商业合同金额、采购规模或短期收入确认路径。
- 项目结果将公开用于科研和AI挑战,更像平台能力展示,不是可直接量化的订单或监管批准催化。
主要风险
- 若后续披露NULISAseq平台获得大额付费采购、临床转化合作或诊断商业化订单,需重新评估。
原文全文
展开原文 · 8,611 字
Alamar Biosciences Partners With Leading Research Universities On National Biomarker Initiative
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Biotech Daily Dose
By
TajSabreen Ahamed
✉
|
Published:
7/13/2026 5:26 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Alamar Biosciences, Inc. (
ALMR
), a precision proteomics company focused on advancing early disease detection, announced a partnership with leading U.S. research universities to launch a national-scale initiative profiling blood-based biomarkers for Alzheimer's disease and related neurodegenerative conditions.
The project will generate large-scale plasma proteomic data from approximately 21,000 samples collected from 10,000 participants enrolled in Alzheimer's Disease Research Centers across the country. Samples are stored at the National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), providing a centralized infrastructure for coordinated biomarker discovery.
Profiling will use Alamar's NULISAseq Neuro220 panel, enhanced with a newly added eMTBR-Tau assay. This enables simultaneous blood-based measurement of tau tangle burden alongside a broad panel of neurodegeneration and neuroinflammation biomarkers. The panel also includes extensive assays for brain-derived tau and alpha-synuclein biology, offering a unique opportunity to study multiple neurodegenerative pathways in deeply characterized participants.
This initiative is co-led by Sarah Biber (Washington University in St. Louis), PhD, Sterling Johnson (University of Wisconsin), PhD, and Tatiana Foroud, PhD (Indiana University, NCRAD). The resulting dataset will be publicly accessible, linked through National Alzheimer's Coordinating Center IDs, and open to AI-driven discovery through a national data challenge.
"Our precision proteomics platform is designed to measure hundreds of low-abundance proteins from blood with attomolar sensitivity, at scale, " said Dr. Yuling Luo, founder and CEO of Alamar. "Applying that capability to a cohort of this size will provide a clinically anchored proteomic dataset that supports discovery, validation, and translational research across neurodegenerative disease."
ALMR has traded between $18.85 and $28.68 over the past year. The stock closed Friday's trading (July 10, 2026) at $28.42, up 7.33%. In pre-market trading the stock is at $28.40, down 0.07%.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Biotech Stocks Facing FDA Decision In May 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher As U.S., Iran Set To Return To Negotiations After Recent Standoff
July 10, 2026 17:00 ET
Crude Oil Moves Lower As Middle East Tensions Gradually Ease
July 10, 2026 14:38 ET
Gold Slides Amid Increasing Inflation Concerns As U.S.-Iran Standoff Continues
July 10, 2026 13:46 ET
U.S. Dollar Slips As U.S.-Iran Standoff Continues While Trump Signals A Deal
July 09, 2026 17:00 ET
Trump Says Ceasefire With Iran Is 'over'
July 08, 2026 07:11 ET
View More
Global Economics Weekly Update - June 29 - July 03, 2026
July 03, 2026 16:09 ET
A busy week for economic data saw the release of several reports on the labor market and the manufacturing sector. In the U.S., the jobs report for June was in focus and results of the latest ISM purchasing managers’ survey threw light on the health of the factory sector. In Europe, results of the PMI surveys gained attention while the unemployment figures from Germany were also in news. Similarly in Asia, survey data on the Chinese manufacturing sector was the highlight.
View More Videos
RELATED NEWS
Alamar Biosciences Launches EMTBR-Tau Immunoassay For Alzheimer's Disease
Alamar Biosciences Prices Upsized IPO At $17/shr; Raises $191.3 Mln
Alamar Prices IPO At $17 Per Share
Latest Updates on COVID-19
KFF Poll Finds AI Health Chatbot Users More Likely To Believe Vaccine Myths
July 01, 2026 14:27 ET
New Study Shows Updated COVID Vaccine Reduces Severe Illness And Hospitalizations
June 24, 2026 13:12 ET
Editor's Pick
Most Read
Most Emailed
Castlelake To Consider Options For EasyJet In View Of Apollo's Counter-Bid
July 10, 2026 11:27 ET
Delta Air Lines Q2 Profit Declines; Affirms FY26 Outlook
July 10, 2026 08:14 ET
U.S. Existing Home Sales Unexpectedly Pull Back Sharply In June
July 09, 2026 10:32 ET
U.S. Weekly Jobless Claims Unexpectedly Edge Down To 215,000
July 09, 2026 10:08 ET
PepsiCo Q2 Profit Surges, Core Margin Drops, Confirms FY26 View; Stock Down
July 09, 2026 09:38 ET
Cottonwood Fire Chars 558 Square Miles Of Utah
July 09, 2026 08:00 ET
Fed Minutes Confirm Mixed Views About Outlook For Rates
July 08, 2026 14:22 ET
Apple Signs Over $30 Bln Worth Chip Deal With Broadcom To Boost U.S. Manufacturing
July 08, 2026 09:13 ET
CDC Warns Of E. Coli Outbreak Linked To Frozen Blueberries
July 08, 2026 07:37 ET
Ebola Continues To Spread In DRC As Death Toll Passes 500, WHO Warns
July 08, 2026 07:30 ET
Argentina Scrapes Through From Verge Of Defeat Against Egypt
July 08, 2026 07:19 ET
Accenture, Leonardo To Build NATO Secure Cloud Platform
July 08, 2026 01:18 ET
Judge Allows Lawsuit Over United's 'Window Seats' Without Windows To Proceed
July 08, 2026 17:37 ET
Netflix Explores Live TV And Bundles To Boost Viewer Engagement: WSJ Reports
July 10, 2026 01:12 ET
OpenAI Says GPT-5.6 Will Be Preferred AI Model For Microsoft 365 Copilot
July 10, 2026 16:33 ET
SFS To Acquire Heartland Precision Fasteners; Price Agreed To Be Confidential
July 10, 2026 03:42 ET
Dream Finders Homes Submits Revised Acquisition Proposal Of $32/Share To Beazer Homes USA
July 08, 2026 07:39 ET
Data I/O To Buy Embedded Software Security IP & Related Assets From IAR Systems For Undisclosed Sum
July 10, 2026 10:17 ET
AstraZeneca: CARDIO-TTRansform Phase III Trial For Wainua Fails To Meet Primary Efficacy Endpoint
July 09, 2026 02:30 ET
Columbus Circle Capital Announces Pricing Of 20 Mln Units IPO At $10/Unit
July 09, 2026 02:06 ET
Freedom Metals Acquisition Prices $275 Mln IPO At $10/unit
July 08, 2026 01:23 ET
Life Corp Profit Falls In Q1
July 08, 2026 01:24 ET
Genworth Financial CEO Tom McInerney To Take Temporary Leave Of Absence
July 08, 2026 01:30 ET
Kering's Gucci Brand To Break Deal With Coty Ahead Of Schedule; In 50-Year Licence Deal With L'Oréal
July 08, 2026 01:29 ET
MasTec To Acquire Superior Group
July 08, 2026 01:36 ET
FuelCell Energy Prices Upsized $225 Mln Stock Offering At $21/shr
July 08, 2026 01:33 ET
Rivian Automotive Prices Underwritten Public Offering Of 75 Mln Shares At $15.50/shr
July 08, 2026 02:02 ET
Admicom Oyj Profit Declines In Q2
July 08, 2026 01:55 ET
Senior Plc Raises Full-year Outlook On Strong Aerospace And Flexonics Performance
July 08, 2026 02:33 ET
NATO Chooses Saab GlobalEye As Future AEW&C Platform
July 08, 2026 01:59 ET
Vistry Group Chief Financial Officer Tim Lawlor To Step Down
July 08, 2026 02:41 ET
Editors Pick
General Mills Shares Gain On Higher Q4 Adj. Earnings, Sales Growth; $3 Bln Cost Savings Target
July 01, 2026 09:55 ET
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
Biotech Daily Dose
By
TajSabreen Ahamed
✉
|
Published:
7/13/2026 5:26 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Alamar Biosciences, Inc. (
ALMR
), a precision proteomics company focused on advancing early disease detection, announced a partnership with leading U.S. research universities to launch a national-scale initiative profiling blood-based biomarkers for Alzheimer's disease and related neurodegenerative conditions.
The project will generate large-scale plasma proteomic data from approximately 21,000 samples collected from 10,000 participants enrolled in Alzheimer's Disease Research Centers across the country. Samples are stored at the National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), providing a centralized infrastructure for coordinated biomarker discovery.
Profiling will use Alamar's NULISAseq Neuro220 panel, enhanced with a newly added eMTBR-Tau assay. This enables simultaneous blood-based measurement of tau tangle burden alongside a broad panel of neurodegeneration and neuroinflammation biomarkers. The panel also includes extensive assays for brain-derived tau and alpha-synuclein biology, offering a unique opportunity to study multiple neurodegenerative pathways in deeply characterized participants.
This initiative is co-led by Sarah Biber (Washington University in St. Louis), PhD, Sterling Johnson (University of Wisconsin), PhD, and Tatiana Foroud, PhD (Indiana University, NCRAD). The resulting dataset will be publicly accessible, linked through National Alzheimer's Coordinating Center IDs, and open to AI-driven discovery through a national data challenge.
"Our precision proteomics platform is designed to measure hundreds of low-abundance proteins from blood with attomolar sensitivity, at scale, " said Dr. Yuling Luo, founder and CEO of Alamar. "Applying that capability to a cohort of this size will provide a clinically anchored proteomic dataset that supports discovery, validation, and translational research across neurodegenerative disease."
ALMR has traded between $18.85 and $28.68 over the past year. The stock closed Friday's trading (July 10, 2026) at $28.42, up 7.33%. In pre-market trading the stock is at $28.40, down 0.07%.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Biotech Stocks Facing FDA Decision In May 2026
Latest Updates on Middle East War
U.S. Dollar Ticks Higher As U.S., Iran Set To Return To Negotiations After Recent Standoff
July 10, 2026 17:00 ET
Crude Oil Moves Lower As Middle East Tensions Gradually Ease
July 10, 2026 14:38 ET
Gold Slides Amid Increasing Inflation Concerns As U.S.-Iran Standoff Continues
July 10, 2026 13:46 ET
U.S. Dollar Slips As U.S.-Iran Standoff Continues While Trump Signals A Deal
July 09, 2026 17:00 ET
Trump Says Ceasefire With Iran Is 'over'
July 08, 2026 07:11 ET
View More
Global Economics Weekly Update - June 29 - July 03, 2026
July 03, 2026 16:09 ET
A busy week for economic data saw the release of several reports on the labor market and the manufacturing sector. In the U.S., the jobs report for June was in focus and results of the latest ISM purchasing managers’ survey threw light on the health of the factory sector. In Europe, results of the PMI surveys gained attention while the unemployment figures from Germany were also in news. Similarly in Asia, survey data on the Chinese manufacturing sector was the highlight.
View More Videos
RELATED NEWS
Alamar Biosciences Launches EMTBR-Tau Immunoassay For Alzheimer's Disease
Alamar Biosciences Prices Upsized IPO At $17/shr; Raises $191.3 Mln
Alamar Prices IPO At $17 Per Share
Latest Updates on COVID-19
KFF Poll Finds AI Health Chatbot Users More Likely To Believe Vaccine Myths
July 01, 2026 14:27 ET
New Study Shows Updated COVID Vaccine Reduces Severe Illness And Hospitalizations
June 24, 2026 13:12 ET
Editor's Pick
Most Read
Most Emailed
Castlelake To Consider Options For EasyJet In View Of Apollo's Counter-Bid
July 10, 2026 11:27 ET
Delta Air Lines Q2 Profit Declines; Affirms FY26 Outlook
July 10, 2026 08:14 ET
U.S. Existing Home Sales Unexpectedly Pull Back Sharply In June
July 09, 2026 10:32 ET
U.S. Weekly Jobless Claims Unexpectedly Edge Down To 215,000
July 09, 2026 10:08 ET
PepsiCo Q2 Profit Surges, Core Margin Drops, Confirms FY26 View; Stock Down
July 09, 2026 09:38 ET
Cottonwood Fire Chars 558 Square Miles Of Utah
July 09, 2026 08:00 ET
Fed Minutes Confirm Mixed Views About Outlook For Rates
July 08, 2026 14:22 ET
Apple Signs Over $30 Bln Worth Chip Deal With Broadcom To Boost U.S. Manufacturing
July 08, 2026 09:13 ET
CDC Warns Of E. Coli Outbreak Linked To Frozen Blueberries
July 08, 2026 07:37 ET
Ebola Continues To Spread In DRC As Death Toll Passes 500, WHO Warns
July 08, 2026 07:30 ET
Argentina Scrapes Through From Verge Of Defeat Against Egypt
July 08, 2026 07:19 ET
Accenture, Leonardo To Build NATO Secure Cloud Platform
July 08, 2026 01:18 ET
Judge Allows Lawsuit Over United's 'Window Seats' Without Windows To Proceed
July 08, 2026 17:37 ET
Netflix Explores Live TV And Bundles To Boost Viewer Engagement: WSJ Reports
July 10, 2026 01:12 ET
OpenAI Says GPT-5.6 Will Be Preferred AI Model For Microsoft 365 Copilot
July 10, 2026 16:33 ET
SFS To Acquire Heartland Precision Fasteners; Price Agreed To Be Confidential
July 10, 2026 03:42 ET
Dream Finders Homes Submits Revised Acquisition Proposal Of $32/Share To Beazer Homes USA
July 08, 2026 07:39 ET
Data I/O To Buy Embedded Software Security IP & Related Assets From IAR Systems For Undisclosed Sum
July 10, 2026 10:17 ET
AstraZeneca: CARDIO-TTRansform Phase III Trial For Wainua Fails To Meet Primary Efficacy Endpoint
July 09, 2026 02:30 ET
Columbus Circle Capital Announces Pricing Of 20 Mln Units IPO At $10/Unit
July 09, 2026 02:06 ET
Freedom Metals Acquisition Prices $275 Mln IPO At $10/unit
July 08, 2026 01:23 ET
Life Corp Profit Falls In Q1
July 08, 2026 01:24 ET
Genworth Financial CEO Tom McInerney To Take Temporary Leave Of Absence
July 08, 2026 01:30 ET
Kering's Gucci Brand To Break Deal With Coty Ahead Of Schedule; In 50-Year Licence Deal With L'Oréal
July 08, 2026 01:29 ET
MasTec To Acquire Superior Group
July 08, 2026 01:36 ET
FuelCell Energy Prices Upsized $225 Mln Stock Offering At $21/shr
July 08, 2026 01:33 ET
Rivian Automotive Prices Underwritten Public Offering Of 75 Mln Shares At $15.50/shr
July 08, 2026 02:02 ET
Admicom Oyj Profit Declines In Q2
July 08, 2026 01:55 ET
Senior Plc Raises Full-year Outlook On Strong Aerospace And Flexonics Performance
July 08, 2026 02:33 ET
NATO Chooses Saab GlobalEye As Future AEW&C Platform
July 08, 2026 01:59 ET
Vistry Group Chief Financial Officer Tim Lawlor To Step Down
July 08, 2026 02:41 ET
Editors Pick
General Mills Shares Gain On Higher Q4 Adj. Earnings, Sales Growth; $3 Bln Cost Savings Target
July 01, 2026 09:55 ET
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。